Work

Navigating Nanoparticles Limitations: Exploring the Advantages of Lipid-Polymer Hybrid Nanoparticles in Disease Management and Cancer Therapy

Year: 2024

Type: article

Abstract: Nanoparticles have appeared as key resources in biomedical applications, significantly enhancing drug release and pharmacological effectiveness. However, traditional nanoparticles exhibit critical limitations, including poor stability, potential cytotoxicity, and suboptimal targeting capabilities, which impede their clinical translation. Researchers are developing lipid-polymer hybrid nanoparticles (LPHNs) to subdue the barriers of traditional nanoparticles. This review reveals the disadvantages of conventional systems and presents LPHNs as a superior alternative, offering enhanced stability, improved drug loading, and targeted delivery.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14002653

Author: Snehalatha. G, Shailaja Pashikanti, Reshma Sanapala, Sudhakar Reddy. N

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6911602894

FWCI:

Cites:

Cited by:

Related to: